Herpes Zoster, Hepatitis C, and Tuberculosis Risk with Apremilast Compared to Biologics, DMARDs and Corticosteroids to Treat Psoriasis and Psoriatic Arthritis

PURPOSE: Psoriasis and psoriatic arthritis (PsA) are associated with an increased infection risk. In this cohort study of patients with treated psoriasis or PsA, we used MarketScan (2014–2018) to estimate rates of herpes zoster, hepatitis C (HepC) and tuberculosis (TB) with apremilast compared to ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagberg, Katrina Wilcox, Persson, Rebecca, Vasilakis-Scaramozza, Catherine, Niemcryk, Steve, Peng, Michael, Paris, Maria, Lindholm, Anders, Jick, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024766/
https://www.ncbi.nlm.nih.gov/pubmed/32104099
http://dx.doi.org/10.2147/CLEP.S239511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024766/
https://www.ncbi.nlm.nih.gov/pubmed/32104099
http://dx.doi.org/10.2147/CLEP.S239511

Ejemplares similares